Aneurysmal Change of the Ductus Arteriosus After Prostaglandin E1 Administration for Pulmonary Atresia: Demonstration with Magnetic Resonance Imaging
Overview
Overview
Journal
Pediatr Cardiol
Specialties
Cardiology & Vascular Diseases
Pediatrics
Pediatrics
Date
1994 Jan 1
PMID
8115269
Citations
1
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
We report a case of pulmonary atresia in which the ductus arteriosus underwent aneurysmal dilatation after infusion of prostaglandin E1 incorporated in lipid microspheres. To our knowledge this is the first case in which this rare morphological change has been demonstrated with the noninvasive method of magnetic resonance imaging.
Citing Articles
PROSTAGLANDINS IN CONGENITAL HEART DISEASE.
Sharma M, Sasikumar M, Karloopia S, Shahi B Med J Armed Forces India. 2016; 57(2):134-8.
PMID: 27407318 PMC: 4925861. DOI: 10.1016/S0377-1237(01)80134-9.
References
1.
Ueda K, Saito A, Nakano H, Aoshima M, Yokota M, Muraoka R
. Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. J Pediatr. 1980; 97(5):834-6.
DOI: 10.1016/s0022-3476(80)80282-4.
View
2.
Pitlick P, French J, Maze A, Kimble K, Ariagno R, Reitz B
. Long-term low-dose prostaglandin E1 administration. J Pediatr. 1980; 96(2):318-20.
DOI: 10.1016/s0022-3476(80)80838-9.
View
3.
Silver M, Freedom R, Silver M, Olley P
. The morphology of the human newborn ductus arteriosus: a reappraisal of its structure and closure with special reference to prostaglandin E1 therapy. Hum Pathol. 1981; 12(12):1123-36.
DOI: 10.1016/s0046-8177(81)80333-4.
View
4.
Lewis A, Freed M, Heymann M, Roehl S, Kensey R
. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation. 1981; 64(5):893-8.
DOI: 10.1161/01.cir.64.5.893.
View
5.
Cole R, Abman S, Aziz K, Bharati S, Lev M
. Prolonged prostaglandin E1 infusion: histologic effects on the patent ductus arteriosus. Pediatrics. 1981; 67(6):816-9.
View